Plain-English translation of NCT06271330 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Age-related Macular Degeneration research guide →This study is looking at what happens when people with age-related macular degeneration (a condition affecting central vision) switch from their current eye injections to a newer medication called . The study is collecting real-world information from people who have already made this switch to see how well the medication works in everyday practice.
Many patients on current eye injection treatments need injections very frequently—sometimes every few weeks—which can be burdensome and affect quality of life. This medication was designed to work longer between injections, potentially giving patients more time between doctor visits while keeping their vision protected.
You likely qualify if…
You likely don't qualify if…
This is a research study that looks back at real medical records from patients who have already switched to the newer medication. You would not receive new injections as part of this study—instead, researchers would review your existing eye care records and treatment history to learn how well the switch worked for you. The study involves collecting and analyzing information from about 100 patients across multiple hospitals.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
France